Browsing Tag
Quince Therapeutics
2 posts
QNCX: What does the reverse merger hunt at Quince Therapeutics mean for shareholders after the NEAT trial collapse?
Quince Therapeutics (Nasdaq: QNCX) has no pipeline and a September Nasdaq deadline. Here's what the reverse merger hunt actually means for retail investors watching this stock.
IntraBio files first-ever FDA application for an Ataxia-Telangiectasia drug with AQNEURSA sNDA submission
IntraBio filed the first-ever FDA application for Ataxia-Telangiectasia via an AQNEURSA sNDA. Read what the Phase III data means for patients and the rare disease market.